A Phase 2a clinical trial is underway to test the possible benefits of sodium selenate for people living with frontotemporal dementia. While Alzheimer’s is…
UPDATE: 3 March 2024, 8:18 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Apathy is an extremely common symptom of Alzheimer’s. It impairs patients’ ability to socialize and maintain routines, activities that are central to preserving their…
An emerging brain technology — transcranial magnetic stimulation — offers a non-invasive way to change the brain for the better, using magnets. Proponents believe…
A recent analysis reveals that people with Alzheimer’s taking Alzheimer’s drug galantamine (Razadyne), approved nearly two decades ago, show moderate cognitive benefits as well…
UPDATE: 3 March 2024, 8:22 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Image: Aduhelm, Biogen/AP. “The approach I’ve been taking is that each decision about whether or not to offer this as a treatment has to…
Looking for answers about Alzheimer’s treatment Aduhelm (generic name aducanumab)? Here’s a primer on what it is, what it does, and more, according to…
“Historic moment:” Today, the FDA gave Biogen’s investigational Alzheimer’s drug aducanumab its approval, with the requirement that they conduct a post-approval trial. UPDATE: 3…
As part of our BrainTalk series, Being Patient spoke with Sandra Kooij about the symptoms and treatment options of ADHD for older adults and…
Pharmaceutical companies are making plans to leverage the emerging technology of quantum computing in hopes of accelerating the search for the next Alzheimer’s treatment….
Dementia is notoriously difficult to accurately diagnose. Parkinson’s disease dementia and Lewy body dementia can be especially hard to tell apart, even for experts….
Melissa J. Armstrong, associate professor of neurology at the University of Floria, discusses the early signs of Lewy body dementia and the importance of…
As part of our BrainTalk series, newscaster Genevieve Glass speaks with Dr. Michael Geschwind about the causes of rapidly progressive dementias — relatively uncommon…
In search of an animal model more comparable to the human brain, Alzheimer’s researchers are turning from mice to monkeys. Animal testing remains controversial,…